Compugen (CGEN)

482
+9(+1.88%)
  • Volume:
    55,367
  • Bid/Ask:
    482/485
  • Day's Range:
    479 - 486

CGEN Overview

Prev. Close
473
Day's Range
479-486
Revenue
6M
Open
479
52 wk Range
472-2,358
EPS
-0.393
Volume
55,367
Market Cap
417.53M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
89,869
P/E Ratio
-3.68
Beta
2.1
1-Year Change
-78.76%
Shares Outstanding
86,624,643
Next Earnings Date
10 Nov 2022
What is your sentiment on Compugen?
or
Vote to see community's results!

Compugen News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Compugen Company Profile

Compugen Company Profile

Employees
73
Market
Israel
  • Type:Equity
  • Market:Israel
  • ISIN:IL0010852080
  • S/N:1085208

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • $20.00 -$25.00 APRIL
    0
    • Why?
      0
    • Why?
      0